FDA opens door to wider use of testosterone therapy for low libido

The FDA may allow broader access to testosterone therapy for men with low libido without known medical cause. Manufacturers ...
Insurancenewsnet.com

“Testosterone Kit” in Patent Application Approval Process (USPTO 20160120712)

This patent application has not been assigned to a company or institution. The following quote was obtained by the news editors from the background information supplied by the inventors: "With the ...
Business Wire

Marius Pharmaceuticals Submits New Drug Application to U.S. FDA for Next-Generation Oral Testosterone Replacement Therapy in Male Patients With Hypogonadism

RALEIGH, N.C.--(BUSINESS WIRE)--Marius Pharmaceuticals, a specialty pharmaceutical company focusing on treating conditions that are primarily associated with testosterone deficiency, today announced ...
Healio

FDA approves oral testosterone undecanoate softgel for treatment of hypogonadism

Please provide your email address to receive an email when new articles are posted on . The FDA has approved an oral testosterone undecanoate softgel for men with deficiency or absence of endogenous ...
Knoxville News Sentinel

ARSYNL Rx Introduces First Needle-Free Testosterone HypoSpray® for Men and Women

ARSYNL Rx, a leader in provider-guided telehealth and modern hormone access, today announced the launch of its exclusive HypoSpray® transdermal testosterone option, the first spray-on testosterone ...